11:00am-12:00pm Eastern Time (US)

Hosted by the Rare Histiocytoses Steering Committee

The Rare Histiocytoses Steering Committee is pleased to invite you to the next webinar in this year's series.

The agenda will include the following presentations:

    • Lenalidomide and dexamethasone for Rosai-Dorfman disease - Xinxin Cao, MD, Department of Hematology, Peking Union Medical College Hospital
    • Cobimetinib for Rosai-Dorfman disease - Jithma Abeykoon, MD, Department of Hematology, Mayo Clinic
    • Interruption of targeted therapy in patients with histiocytosis - Eli Diamond, MD, Department of Neurology, Memorial Sloan Kettering Cancer Center
      Registration is now open!

        We look forward to seeing you online!  

        Please Note: This webinar will be open to and intended for Medical Professionals only.  
        Patients and families are encouraged to connect with the Histiocytosis Association for information on upcoming patient and family-focused webinars.

        About the Society

        The Histiocyte Society is a nonprofit organization of more than 200 physicians and scientists from around the world committed to improving the lives of patients with histiocytic disorders by conducting clinical and laboratory research into the causes and treatment of this disease.

        Copyright © 2020 Histiocyte Society


        Phone: +1 856 589 6606 
        Fax: +1 856 589 6614
        332 N Broadway
        Pitman, NJ 08071 USA

        Powered by Wild Apricot Membership Software